Literature DB >> 26317050

Pathophysiological role of enhanced bone marrow adipogenesis in diabetic complications.

Meghan A Piccinin1, Zia A Khan2.   

Abstract

Diabetes leads to complications in select organ systems primarily by disrupting the vasculature of the target organs. These complications include both micro- (cardiomyopathy, retinopathy, nephropathy, and neuropathy) and macro-(atherosclerosis) angiopathies. Bone marrow angiopathy is also evident in both experimental models of the disease as well as in human diabetes. In addition to vascular disruption, bone loss and increased marrow adiposity have become hallmarks of the diabetic bone phenotype. Emerging evidence now implicates enhanced marrow adipogenesis and changes to cellular makeup of the marrow in a novel mechanistic link between various secondary complications of diabetes. In this review, we explore the mechanisms of enhanced marrow adipogenesis in diabetes and the link between changes to marrow cellular composition, and disruption and depletion of reparative stem cells.

Entities:  

Keywords:  adipogenesis; angiogenesis; diabetes; osteoblasts; repair; stem cells

Year:  2014        PMID: 26317050      PMCID: PMC4550679          DOI: 10.4161/adip.32215

Source DB:  PubMed          Journal:  Adipocyte        ISSN: 2162-3945            Impact factor:   4.534


  160 in total

Review 1.  Vascular repair by endothelial progenitor cells.

Authors:  Anna Zampetaki; John Paul Kirton; Qingbo Xu
Journal:  Cardiovasc Res       Date:  2008-03-18       Impact factor: 10.787

2.  The rising global burden of diabetes and its complications: estimates and projections to the year 2010.

Authors:  A F Amos; D J McCarty; P Zimmet
Journal:  Diabet Med       Date:  1997       Impact factor: 4.359

Review 3.  Adipocyte differentiation: a transcriptional regulatory cascade.

Authors:  R P Brun; J B Kim; E Hu; S Altiok; B M Spiegelman
Journal:  Curr Opin Cell Biol       Date:  1996-12       Impact factor: 8.382

4.  Rosiglitazone stimulates adipogenesis and decreases osteoblastogenesis in human mesenchymal stem cells.

Authors:  S Benvenuti; I Cellai; P Luciani; C Deledda; S Baglioni; C Giuliani; R Saccardi; B Mazzanti; S Dal Pozzo; E Mannucci; A Peri; M Serio
Journal:  J Endocrinol Invest       Date:  2007-10       Impact factor: 4.256

5.  Assessing the impact of complications on the costs of Type II diabetes.

Authors:  R Williams; L Van Gaal; C Lucioni
Journal:  Diabetologia       Date:  2002-06-12       Impact factor: 10.122

6.  Free fatty acid profiles in the non-obese diabetic (NOD) mouse: basal serum levels and effects of endocrine manipulation.

Authors:  N Christeff; F Homo-Delarche; N Thobie; S Durant; M Dardenne; E A Nunez
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  1994-08       Impact factor: 4.006

Review 7.  Understanding the pathology and mechanisms of type I diabetic bone loss.

Authors:  Laura R McCabe
Journal:  J Cell Biochem       Date:  2007-12-15       Impact factor: 4.429

8.  Adiponectin stimulates osteoblast differentiation through induction of COX2 in mesenchymal progenitor cells.

Authors:  Hyun Woo Lee; Sang Yun Kim; A Young Kim; Eun Jig Lee; Je-Yong Choi; Jae Bum Kim
Journal:  Stem Cells       Date:  2009-09       Impact factor: 6.277

Review 9.  Vascular stem cells in diabetic complications: evidence for a role in the pathogenesis and the therapeutic promise.

Authors:  Emily C Keats; Zia A Khan
Journal:  Cardiovasc Diabetol       Date:  2012-04-23       Impact factor: 9.951

10.  Unique responses of stem cell-derived vascular endothelial and mesenchymal cells to high levels of glucose.

Authors:  Emily Keats; Zia A Khan
Journal:  PLoS One       Date:  2012-06-06       Impact factor: 3.240

View more
  10 in total

Review 1.  Diabetes and bone health: latest evidence and clinical implications.

Authors:  Vikram Sundararaghavan; Matthew M Mazur; Brad Evans; Jiayong Liu; Nabil A Ebraheim
Journal:  Ther Adv Musculoskelet Dis       Date:  2017-01-24       Impact factor: 5.346

2.  Rosiglitazone induces adipogenesis of both marrow and periosteum derived mesenchymal stem cells during endochondral fracture healing.

Authors:  Devan Mehta; John Dankert; Nury Yim; Kevin Leclerc; Philipp Leucht
Journal:  J Orthop Sci       Date:  2021-12-06       Impact factor: 1.805

Review 3.  Bone Marrow Adipose Tissue and Skeletal Health.

Authors:  Shanmugam Muruganandan; Rajgopal Govindarajan; Christopher J Sinal
Journal:  Curr Osteoporos Rep       Date:  2018-08       Impact factor: 5.096

4.  Therapeutic efficacy of neural stem cells originating from umbilical cord-derived mesenchymal stem cells in diabetic retinopathy.

Authors:  Wei Zhang; Yuexin Wang; Jiahui Kong; Meng Dong; Hongtao Duan; Song Chen
Journal:  Sci Rep       Date:  2017-03-24       Impact factor: 4.379

Review 5.  Molecular Modulation of Osteoblasts and Osteoclasts in Type 2 Diabetes.

Authors:  Selvalakshmi Rathinavelu; Crissy Guidry-Elizondo; Jameela Banu
Journal:  J Diabetes Res       Date:  2018-11-04       Impact factor: 4.011

Review 6.  Pathophysiology and Management of Type 2 Diabetes Mellitus Bone Fragility.

Authors:  C Eller-Vainicher; E Cairoli; G Grassi; F Grassi; A Catalano; D Merlotti; A Falchetti; A Gaudio; I Chiodini; L Gennari
Journal:  J Diabetes Res       Date:  2020-05-22       Impact factor: 4.011

7.  Chondroitin Sulfate Prevents STZ Induced Diabetic Osteoporosis through Decreasing Blood Glucose, AntiOxidative Stress, Anti-Inflammation and OPG/RANKL Expression Regulation.

Authors:  Hong Xing Zheng; De Jing Chen; Yue Xin Zu; En Zhu Wang; Shan Shan Qi
Journal:  Int J Mol Sci       Date:  2020-07-26       Impact factor: 5.923

8.  Experimental Type 2 Diabetes Differently Impacts on the Select Functions of Bone Marrow-Derived Multipotent Stromal Cells.

Authors:  Jonathan Ribot; Cyprien Denoeud; Guilhem Frescaline; Rebecca Landon; Hervé Petite; Graciela Pavon-Djavid; Morad Bensidhoum; Fani Anagnostou
Journal:  Cells       Date:  2021-01-29       Impact factor: 6.600

9.  Increased Bone Marrow Adiposity in a Context of Energy Deficit: The Tip of the Iceberg?

Authors:  Olfa Ghali; Nathalie Al Rassy; Pierre Hardouin; Christophe Chauveau
Journal:  Front Endocrinol (Lausanne)       Date:  2016-09-16       Impact factor: 5.555

Review 10.  When Good Guys Turn Bad: Bone Marrow's and Hematopoietic Stem Cells' Role in the Pathobiology of Diabetic Complications.

Authors:  Maria Cristina Vinci; Elisa Gambini; Beatrice Bassetti; Stefano Genovese; Giulio Pompilio
Journal:  Int J Mol Sci       Date:  2020-05-29       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.